Document Detail


Is it possible to improve neurodevelopmental abnormalities in Down syndrome?
MedLine Citation:
PMID:  21819263     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Abstract Down syndrome (DS) is a genetic pathology caused by the triplication of human chromosome 21. Although individuals with DS have various medical problems, intellectual disability is the most invalidating aspect of the pathology. Despite numerous efforts, the mechanisms whereby gene triplication leads to the DS phenotype have not been elucidated and there are, at present, no therapies to rescue brain developmental alterations and mental disability in individuals with DS. In this review, we focused on the major defects of the DS brain, comparing data regarding humans with DS and mouse models for DS, and therapeutic interventions attempted on animal DS models. Based on the promising results of pharmacotherapies in these models, we believe that it is possible to conclude that tools to improve brain development in DS are now almost at hand. We now know that it is possible to rescue and/or improve neurogenesis, neuron maturation, connectivity, neurodegeneration and behavior. We believe that the knowledge gained in DS mouse models provides a rational basis to start new clinical trials in infants, children and adults with DS, exploiting drugs that have proved able to rescue various facets of the DS neurologic phenotype. It is not unreasonable to consider that the results of these trials may provide a positive answer to the question: 'Is it possible to improve brain development in DS?'.
Authors:
Renata Bartesaghi; Sandra Guidi; Elisabetta Ciani
Related Documents :
2321913 - Multilocus ordering strategies based on sperm typing.
12663553 - Mapping quantitative trait loci in the case of a spike in the phenotype distribution.
22595033 - Dissociation of bold responses to reward prediction errors and reward receipt by a mode...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Reviews in the neurosciences     Volume:  22     ISSN:  0334-1763     ISO Abbreviation:  Rev Neurosci     Publication Date:  2011  
Date Detail:
Created Date:  2011-08-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8711016     Medline TA:  Rev Neurosci     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  419-55     Citation Subset:  IM    
Affiliation:
Department of Human and General Physiology, University of Bologna, Piazza di Porta San Donato 2, I-40126, Bologna, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich...
Next Document:  Translational research in transcranial direct current stimulation (tDCS): a systematic review of stu...